Browsing: Novo

(Reuters) -The Senate Health, Education, Labor and Pensions Committee said on Friday that Novo Nordisk (NYSE:) CEO Lars Jorgensen has…

By Maggie Fick LONDON (Reuters) – Novo Nordisk’s (NYSE:) Wegovy anti-obesity drug reduced adverse kidney-related events by 22% in overweight…

A top exchange-traded fund provider is betting on the long-term popularity of GLP-1 weight loss drugs.Roundhill Investments’ GLP-1 & Weight…

By Sriparna Roy and Mariam Sunny (Reuters) -Advisors to the U.S. health regulator on Friday voted against the use of…